NCT03091309 Counseling to Optimize Adherence in Expectant Mothers With Inflammatory Bowel Disease Status UNKNOWN Phase NA
NCT03071081 Study for Safety and Tolerability of TOP1288 Administered Orally in Healthy Subjects Status COMPLETED Phase PHASE1
NCT03059849 Brief Escalation of Adalimumab Treatment for Prevention of Clinical Relapse in IBD Status WITHDRAWN Phase PHASE4
NCT03053713 The Effect of Diet on Disease Activity and Symptoms in Patients With Ulcerative Colitis Status COMPLETED Phase NA
NCT03051204 OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut Microbiome Status COMPLETED Phase N/A
NCT03038711 A Multiple Dose Study to Assess the Safety and Tolerability of BMS-986166 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT03018925 Golimumab Effect in the Modulation of Gut Microbiota in Ulcerative Colitis Status COMPLETED Phase N/A
NCT03016780 Fecal Microbiota Transplantation for Ulcerative Colitis Status UNKNOWN Phase PHASE1/PHASE2
NCT03011593 Effect of UGIR in Adults With Compromised Gut Function and Malabsorption Status COMPLETED Phase NA
NCT03006809 Optimal Fecal Microbiota Transplant Dosing for Mild to Moderate Ulcerative Colitis Status COMPLETED Phase PHASE1
NCT03000101 Study of the Role of Pomegranate Juice Ellagitannins in the Modulation of Inflammation in Inflammatory Bowel Disease Status COMPLETED Phase NA
NCT02998112 Fecal Microbiota Transplantation for Ulcerative Colitis Through Colonic Transendoscopic Enteral Tubing Status UNKNOWN Phase PHASE4
NCT02962245 Efficacy of Treatment With Berberine to Maintain Remission in Ulcerative Colitis Status WITHDRAWN Phase PHASE4
NCT02958865 Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT02954159 Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UC Status TERMINATED Phase PHASE3
NCT02925338 National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real Life Status COMPLETED Phase N/A